YU46899A - Kontrolisano oslobadjanje farmaceutika u prednjoj komori oka - Google Patents
Kontrolisano oslobadjanje farmaceutika u prednjoj komori okaInfo
- Publication number
- YU46899A YU46899A YU46899A YU46899A YU46899A YU 46899 A YU46899 A YU 46899A YU 46899 A YU46899 A YU 46899A YU 46899 A YU46899 A YU 46899A YU 46899 A YU46899 A YU 46899A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- pharmaceuticals
- anterior chamber
- eye
- controlled release
- anterior
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/08—Mydriatics or cycloplegics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Abstract
Ovaj pronalazak se odnosi na preparate koji održavaju strukturni integritet prednje komore oka za vreme oftalmološke operacije, čime se štite tkiva i linija prednjeg segmenta od potencijalnog oštećenja i istovremeno se obezbedjuje zadržano oslobadjanje farmaceutika, uključujući miotske, midriatske, ili anestetičke agense.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/819,255 US5972326A (en) | 1995-04-18 | 1997-03-18 | Controlled release of pharmaceuticals in the anterior chamber of the eye |
Publications (1)
Publication Number | Publication Date |
---|---|
YU46899A true YU46899A (sh) | 2000-10-30 |
Family
ID=25227627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU46899A YU46899A (sh) | 1997-03-18 | 1998-03-18 | Kontrolisano oslobadjanje farmaceutika u prednjoj komori oka |
Country Status (29)
Country | Link |
---|---|
US (1) | US5972326A (sh) |
EP (1) | EP1027015B1 (sh) |
JP (2) | JP2001516258A (sh) |
KR (1) | KR20000076347A (sh) |
CN (1) | CN1251979A (sh) |
AP (1) | AP9901655A0 (sh) |
AT (1) | ATE288719T1 (sh) |
AU (1) | AU6471698A (sh) |
BG (1) | BG103806A (sh) |
BR (1) | BR9808282A (sh) |
CA (1) | CA2282427C (sh) |
DE (1) | DE69828993T2 (sh) |
DK (1) | DK1027015T3 (sh) |
EA (1) | EA002004B1 (sh) |
EE (1) | EE9900413A (sh) |
ES (1) | ES2237836T3 (sh) |
HU (1) | HUP0001818A3 (sh) |
ID (1) | ID23917A (sh) |
IL (1) | IL131955A0 (sh) |
IS (1) | IS5172A (sh) |
NO (1) | NO994485L (sh) |
NZ (1) | NZ337654A (sh) |
OA (1) | OA11158A (sh) |
PL (1) | PL335801A1 (sh) |
PT (1) | PT1027015E (sh) |
SK (1) | SK127099A3 (sh) |
TR (1) | TR199902253T2 (sh) |
WO (1) | WO1998041171A1 (sh) |
YU (1) | YU46899A (sh) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070185032A1 (en) * | 1996-12-11 | 2007-08-09 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
WO1999006023A1 (en) * | 1997-07-29 | 1999-02-11 | Alcon Laboratories, Inc. | Ophthalmic compositions containing galactomannan polymers and borate |
US6261547B1 (en) | 1998-04-07 | 2001-07-17 | Alcon Manufacturing, Ltd. | Gelling ophthalmic compositions containing xanthan gum |
US20030087962A1 (en) * | 1998-10-20 | 2003-05-08 | Omeros Corporation | Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation |
US7973068B2 (en) * | 1998-10-20 | 2011-07-05 | Omeros Corporation | Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation |
DK172900B1 (da) | 1998-12-18 | 1999-09-27 | Per Julius Nielsen | Præparat samt kit til brug ved intraoculære operationer |
DK1225898T3 (da) | 1999-11-01 | 2003-09-15 | Alcon Inc | Farmaceutisk præparat indeholdende et fluorquinolonantibiotisk lægemiddel og xanthangummi |
ES2168190B1 (es) * | 1999-11-23 | 2003-11-01 | Iglesias Javier Lopez | Uso intraocular de una combinacion de viscoelastico y anestesico (material viscoanestesico). |
US6730691B1 (en) | 2000-02-10 | 2004-05-04 | Miles A. Galin | Uses of alpha adrenergic blocking agents |
MXPA02008966A (es) | 2000-03-14 | 2003-02-12 | Alcon Inc | Viscoelasticos para uso en cirugia del oido medio. |
US20030086899A1 (en) * | 2000-03-14 | 2003-05-08 | Jafari Masoud R. | Chondroitin sulfate containing viscoelastics for use in treating joints |
AU2001270593A1 (en) | 2000-07-28 | 2002-02-13 | Alcon Universal Ltd. | Pharmaceutical compositions containing tobramycin and xanthan gum |
ES2387537T3 (es) | 2000-09-13 | 2012-09-25 | Glaxosmithkline Llc | Composiciones farmacéuticas para la administración sostenida de péptidos |
WO2002040056A2 (en) * | 2000-11-06 | 2002-05-23 | Alcon, Inc | Carrageenan viscoelastics for ocular surgery |
JP2005511477A (ja) * | 2001-03-19 | 2005-04-28 | プラエシス ファーマシューティカルズ インコーポレーテッド | 持続放出のための医薬調合物 |
CA2446741C (en) * | 2001-07-23 | 2009-09-29 | Alcon, Inc. | Ophthalmic drug delivery device |
US7829109B2 (en) | 2001-11-14 | 2010-11-09 | Durect Corporation | Catheter injectable depot compositions and uses thereof |
US7820194B2 (en) * | 2001-12-21 | 2010-10-26 | Alcon, Inc. | Combinations of viscoelastics for use during surgery |
US20040101561A1 (en) * | 2002-11-13 | 2004-05-27 | Jafari Masoud R. | Combinations of viscoelastics for use during surgery |
CA2476120A1 (en) * | 2002-02-14 | 2003-08-21 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Methods and compositions for the treatment of eye diseases |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
CA2866848C (en) | 2002-07-30 | 2017-01-03 | Omeros Corporation | Ophthalmologic irrigation solutions and method |
WO2004012703A1 (en) | 2002-07-31 | 2004-02-12 | Alza Corporation | Injectable depot compositions and uses thereof |
MXPA05001244A (es) | 2002-07-31 | 2005-06-08 | Alza Corp | Composiciones de deposito de polimero multimodal inyectable y usos de las mismas. |
DE10246340A1 (de) * | 2002-10-04 | 2004-04-29 | Wohlrab, David, Dr. | Kombinationspräparat aus Hyaluronsäure und mindestens einem Lokalanästhetikum und dessen Verwendung |
US20040167480A1 (en) * | 2003-02-21 | 2004-08-26 | Advanced Medical Optics, Inc. | Administration of multiple viscoelastic solutions with a multi-compartment syringe |
EP1708722B1 (en) * | 2004-01-28 | 2014-05-21 | The Regents of The University of California | Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis |
DE602005015936D1 (de) * | 2004-02-26 | 2009-09-24 | Bausch & Lomb | Viskoelastische alginat-zusammensetzung, herstellungsverfahren und verpackung |
US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
US8722097B2 (en) | 2004-04-30 | 2014-05-13 | Allergan, Inc. | Oil-in-water method for making polymeric implants containing a hypotensive lipid |
US9498457B2 (en) | 2004-04-30 | 2016-11-22 | Allergan, Inc. | Hypotensive prostamide-containing biodegradable intraocular implants and related implants |
US8673341B2 (en) | 2004-04-30 | 2014-03-18 | Allergan, Inc. | Intraocular pressure reduction with intracameral bimatoprost implants |
US7993634B2 (en) | 2004-04-30 | 2011-08-09 | Allergan, Inc. | Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods |
DE102004021992A1 (de) * | 2004-05-03 | 2005-11-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Topische Zubereitung enthaltend Ambroxol |
EP1827462A4 (en) * | 2004-11-24 | 2012-01-04 | Therakine Ltd | IMPLANT FOR INTRAOCULAR DRUG DELIVERY |
US20060251551A1 (en) * | 2005-05-09 | 2006-11-09 | Brian Johnson | Apparatus and method for ozone gas distribution |
US8367845B2 (en) * | 2006-04-21 | 2013-02-05 | The Trustees Of Boston University | Ionic viscoelastics and viscoelastic salts |
ITPD20060202A1 (it) * | 2006-05-22 | 2007-11-23 | Univ Degli Studi Trieste | Miscele polimeriche di polisaccaridi anionici e cationici e loro impiego |
US20080021068A1 (en) * | 2006-07-24 | 2008-01-24 | Akorn, Inc. | Aqueous gel formulation and method for inducing topical anesthesia |
US20090123527A1 (en) * | 2006-07-24 | 2009-05-14 | Akorn, Inc. | Method of inducing topical anesthesia and transdermal patch |
US8114898B2 (en) | 2007-11-16 | 2012-02-14 | Allergan, Inc. | Compositions and methods for treating purpura |
US8394782B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
US8450475B2 (en) | 2008-08-04 | 2013-05-28 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
ES2658609T3 (es) | 2008-09-02 | 2018-03-12 | Tautona Group Lp | Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos, y usos de los mismos |
FR2938187B1 (fr) * | 2008-11-07 | 2012-08-17 | Anteis Sa | Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur |
US20100247606A1 (en) * | 2009-03-25 | 2010-09-30 | Allergan, Inc. | Intraocular sustained release drug delivery systems and methods for treating ocular conditions |
EP2413894B1 (en) * | 2009-04-02 | 2017-01-04 | Allergan, Inc. | Hair-like shaped hydrogels for soft tissue augmentation |
CN102038953B (zh) * | 2009-10-14 | 2012-07-18 | 上海昊海生物科技股份有限公司 | 一种眼科手术前局部麻醉用组合物及其制备方法和用途 |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
KR102126007B1 (ko) | 2010-01-22 | 2020-06-24 | 알러간, 인코포레이티드 | 전방내 서방성 치료제 이식물 |
CA2792729C (en) | 2010-03-12 | 2016-06-28 | Allergan Industrie, Sas | Fluid compositions for improving skin conditions |
EP2550027B2 (en) | 2010-03-22 | 2019-03-20 | Allergan, Inc. | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
FR2968996B1 (fr) * | 2010-12-17 | 2013-04-12 | Anteis Sa | Formulation aqueuse injectable sterile utilisee en ophtalmologie |
EP2675455A4 (en) * | 2011-02-18 | 2014-07-16 | M S Appasamy Associates | OPHTHALMIC COMPOSITION FOR DILATING PUPILS |
US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
CN107412002A (zh) | 2011-06-03 | 2017-12-01 | 阿勒根公司 | 包括抗氧化剂的皮肤填充剂组合物 |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
CN102949755B (zh) * | 2011-08-16 | 2015-04-08 | 上海建华精细生物制品有限公司 | 一种含有局麻药物的医用腔道窥镜润滑胶制备方法及其用途 |
US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
EP2581079B1 (en) | 2011-10-11 | 2016-12-07 | BioPolymer GmbH & Co. KG | Combination of hyaluronic acid and prilocaine |
GB2501943B (en) * | 2012-05-10 | 2020-09-23 | Zeiss Carl Meditec Ag | Ophthalmic viscoelastic device |
AU2013201465B2 (en) | 2012-10-24 | 2016-03-03 | Rayner Surgical (Ireland) Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
CA2931547A1 (en) | 2013-12-09 | 2015-06-18 | Durect Corporation | Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same |
RU2563232C1 (ru) * | 2014-04-01 | 2015-09-20 | Общество с ограниченной ответственностью "КОЛЕТЕКС" | Способ получения лечебного гидрогеля |
EP3620184A1 (en) | 2014-09-30 | 2020-03-11 | Allergan Industrie, SAS | Stable hydrogel compositions including additives |
TWI705812B (zh) | 2014-12-01 | 2020-10-01 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
FR3036035B1 (fr) * | 2015-05-11 | 2018-10-05 | Laboratoires Vivacy | Compositions comprenant au moins un polyol et au moins un anesthesique |
US10004824B2 (en) | 2015-05-11 | 2018-06-26 | Laboratoires Vivacy | Compositions comprising at least one polyol and at least one anesthetic |
BR112019002967A2 (pt) * | 2016-08-19 | 2019-05-14 | Orasis Pharmaceuticals Ltd. | composição farmacêutica oftálmica, métodos de corrigir presbiopia, de reduzir o tamanho de uma pupila, de induzir miose, de aumentar a profundidade de campo, de diminuir a grandeza de aberrações de ordem superior e de melhorar a acuidade visual não corrigida de perto e de longe, implante, e, kit. |
FR3086865B1 (fr) * | 2018-10-04 | 2023-04-28 | Matthieu Leconte | Preparation ophtalmique et lentille d'orthokeratologie pour l'inhibition, la prevention et/ou la limitation de la progression de la myopie |
CN115666621A (zh) | 2020-01-13 | 2023-01-31 | 度勒科特公司 | 具有减少的杂质的持续释放药物递送系统及相关方法 |
DE202021003113U1 (de) | 2021-10-04 | 2021-10-21 | Qais Aburok | Wirkstoffkombination aus Lidocain und Allcin gegen Irritationen der Haut und Schleimhäute |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1113760A (en) * | 1966-12-16 | 1968-05-15 | Barnes Hind Lab Inc | Ophthalmic composition |
IL50250A (en) * | 1975-08-27 | 1980-01-31 | Hydrophilics Int Inc | Sustained release compositions comprising slats of pharmaceutically acitve bases with polymers containing acid groups |
US4141973A (en) * | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
US4305927A (en) * | 1979-02-05 | 1981-12-15 | Alza Corporation | Method for the management of intraocular pressure |
US4303637A (en) * | 1980-04-04 | 1981-12-01 | Alza Corporation | Medication indicated for ocular hypertension |
US5166331A (en) * | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
IT1229075B (it) * | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico |
US4911920A (en) * | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
US4668506A (en) * | 1985-08-16 | 1987-05-26 | Bausch & Lomb Incorporated | Sustained-release formulation containing and amino acid polymer |
US4931279A (en) * | 1985-08-16 | 1990-06-05 | Bausch & Lomb Incorporated | Sustained release formulation containing an ion-exchange resin |
US4713244A (en) * | 1985-08-16 | 1987-12-15 | Bausch & Lomb Incorporated | Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent |
US4863457A (en) * | 1986-11-24 | 1989-09-05 | Lee David A | Drug delivery device |
US5093126A (en) * | 1987-09-26 | 1992-03-03 | Alcon Laboratories, Inc. | Glaucoma formulations comprising an anionic, polysulfonic acid polymer having mucomimetic properties and a polystyrene sulfonic polymer |
US4902692A (en) * | 1988-03-18 | 1990-02-20 | Iolab Corporation | Method and composition for ophthalmic anesthesia using rodocaine |
JPH0236128A (ja) * | 1988-07-25 | 1990-02-06 | Kiyoshi Kita | 眼内注射剤 |
US5098443A (en) * | 1989-03-23 | 1992-03-24 | University Of Miami | Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents |
US5007913A (en) * | 1989-09-19 | 1991-04-16 | Alcon Surgical, Inc. | Apparatus and method for implantation of intraocular lenses |
US5318780A (en) * | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
US5612027A (en) * | 1995-04-18 | 1997-03-18 | Galin; Miles A. | Controlled release of miotic and mydriatic drugs in the anterior chamber |
-
1997
- 1997-03-18 US US08/819,255 patent/US5972326A/en not_active Expired - Lifetime
-
1998
- 1998-03-18 NZ NZ337654A patent/NZ337654A/en unknown
- 1998-03-18 DK DK98910483T patent/DK1027015T3/da active
- 1998-03-18 EE EEP199900413A patent/EE9900413A/xx unknown
- 1998-03-18 TR TR1999/02253T patent/TR199902253T2/xx unknown
- 1998-03-18 KR KR1019997008448A patent/KR20000076347A/ko not_active Application Discontinuation
- 1998-03-18 AP APAP/P/1999/001655A patent/AP9901655A0/en unknown
- 1998-03-18 SK SK1270-99A patent/SK127099A3/sk unknown
- 1998-03-18 AU AU64716/98A patent/AU6471698A/en not_active Abandoned
- 1998-03-18 AT AT98910483T patent/ATE288719T1/de active
- 1998-03-18 JP JP54076298A patent/JP2001516258A/ja not_active Withdrawn
- 1998-03-18 EA EA199900811A patent/EA002004B1/ru not_active IP Right Cessation
- 1998-03-18 HU HU0001818A patent/HUP0001818A3/hu unknown
- 1998-03-18 CN CN98804137A patent/CN1251979A/zh active Pending
- 1998-03-18 CA CA002282427A patent/CA2282427C/en not_active Expired - Fee Related
- 1998-03-18 WO PCT/US1998/005320 patent/WO1998041171A1/en active IP Right Grant
- 1998-03-18 YU YU46899A patent/YU46899A/sh unknown
- 1998-03-18 EP EP98910483A patent/EP1027015B1/en not_active Expired - Lifetime
- 1998-03-18 ES ES98910483T patent/ES2237836T3/es not_active Expired - Lifetime
- 1998-03-18 BR BR9808282-5A patent/BR9808282A/pt unknown
- 1998-03-18 ID IDW991049A patent/ID23917A/id unknown
- 1998-03-18 DE DE69828993T patent/DE69828993T2/de not_active Expired - Lifetime
- 1998-03-18 PT PT98910483T patent/PT1027015E/pt unknown
- 1998-03-18 PL PL98335801A patent/PL335801A1/xx unknown
- 1998-03-18 IL IL13195598A patent/IL131955A0/xx unknown
-
1999
- 1999-09-07 IS IS5172A patent/IS5172A/is unknown
- 1999-09-15 OA OA9900209A patent/OA11158A/en unknown
- 1999-09-16 NO NO994485A patent/NO994485L/no not_active Application Discontinuation
- 1999-10-13 BG BG103806A patent/BG103806A/xx unknown
-
2010
- 2010-07-02 JP JP2010151871A patent/JP2010269155A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU46899A (sh) | Kontrolisano oslobadjanje farmaceutika u prednjoj komori oka | |
MX9708043A (es) | Liberacion controlada de farmacos mioticos y midriaticos en la camara anterior. | |
ATE426413T1 (de) | Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen | |
MX9702349A (es) | Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma. | |
BR0302584A (pt) | Combinação de brimonidina e timolol para uso oftálmico tópico | |
ES2062102T3 (es) | Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular. | |
DE69620724D1 (de) | Ophthalmische Formulierung auf Natriumhyaluronatbasis zur Verwendung in der Augenchirurgie | |
ATE303757T1 (de) | Behandlung von augenerkrankungen | |
DE69917040D1 (de) | Augenlösung mit tetracyclin für behandlung von trockenen augen | |
JP2005523928A5 (sh) | ||
BR0210241A (pt) | Piranoindazóis e seu uso no tratamento de glaucoma | |
ATE319458T1 (de) | Medizinische zusammensetzungen zur behandlung von augenerkrankungen | |
ATE274918T1 (de) | Albumin als aktiven bestandteil zur behandlung von bindehaut- und hornhautverletzungen und von trockenen augen | |
BR9913955A (pt) | Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular | |
BR9914128A (pt) | Composições antibióticas para tratamento do olho, ouvido e nariz | |
ATE227135T1 (de) | Miotische wirkstoffe und hypertonische wirkstoffe enthaltende ophthalmische zusammensetzungen | |
SE9201425D0 (sv) | Method and means for preventing constriction of the pupil in the eye | |
SE8901149D0 (sv) | Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat | |
PT1169026E (pt) | Utilizacao de activadores de ap-1 no tratamento do glaucoma e da hipertensao ocular | |
ATE204169T1 (de) | Polyamin-antagonisten enthaltende intraokulare irrigationslösung | |
UA29334A (uk) | Очні краплі | |
RU94001223A (ru) | Глазные капли | |
UY25908A1 (es) | Composiciones oftálmicas que contienen ciclosporina, un surfactante y un vehículo acuoso |